\nThe Conexus telemetry protocol utilized within Medtronic MyCareLink Monitor versions 24950 and 24952, CareLink Monitor version 2490C, CareLink 2090 Programmer, Amplia CRT-D, Claria CRT-D, Compia CRT-D, Concerto CRT-D, Concerto II CRT-D, Consulta CRT-D, Evera ICD, Maximo II CRT-D and ICD, Mirro ICD, Nayamed ND ICD, Primo ICD, Protecta ICD and CRT-D, Secura ICD, Virtuoso ICD, Virtuoso II ICD, Visia AF ICD, and Viva CRT-D does not implement authentication or authorization. An attacker with adjacent short-range access to an affected product, in situations where the product’s radio is turned on, can inject, replay, modify, and/or intercept data within the telemetry communication. This communication protocol provides the ability to read and write memory values to affected implanted cardiac devices; therefore, an attacker could exploit this communication protocol to change memory in the implanted cardiac device.\n\n
"}],"value":"The Conexus telemetry protocol utilized within Medtronic MyCareLink Monitor versions 24950 and 24952, CareLink Monitor version 2490C, CareLink 2090 Programmer, Amplia CRT-D, Claria CRT-D, Compia CRT-D, Concerto CRT-D, Concerto II CRT-D, Consulta CRT-D, Evera ICD, Maximo II CRT-D and ICD, Mirro ICD, Nayamed ND ICD, Primo ICD, Protecta ICD and CRT-D, Secura ICD, Virtuoso ICD, Virtuoso II ICD, Visia AF ICD, and Viva CRT-D does not implement authentication or authorization. An attacker with adjacent short-range access to an affected product, in situations where the product’s radio is turned on, can inject, replay, modify, and/or intercept data within the telemetry communication. This communication protocol provides the ability to read and write memory values to affected implanted cardiac devices; therefore, an attacker could exploit this communication protocol to change memory in the implanted cardiac device."}],"metrics":[{"cvssV3_1":{"attackComplexity":"LOW","attackVector":"ADJACENT_NETWORK","availabilityImpact":"HIGH","baseScore":9.3,"baseSeverity":"CRITICAL","confidentialityImpact":"NONE","integrityImpact":"HIGH","privilegesRequired":"NONE","scope":"CHANGED","userInteraction":"NONE","vectorString":"CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:C/C:N/I:H/A:H","version":"3.1"},"format":"CVSS","scenarios":[{"lang":"en","value":"GENERAL"}]}],"problemTypes":[{"descriptions":[{"cweId":"CWE-284","description":"CWE-284","lang":"en","type":"CWE"}]}],"providerMetadata":{"orgId":"7d14cffa-0d7d-4270-9dc0-52cabd5a23a6","shortName":"icscert","dateUpdated":"2025-05-22T19:26:15.126Z"},"references":[{"tags":["x_refsource_MISC"],"url":"https://ics-cert.us-cert.gov/advisories/ICSMA-19-080-01"},{"name":"107544","tags":["vdb-entry","x_refsource_BID"],"url":"http://www.securityfocus.com/bid/107544"}],"solutions":[{"lang":"en","supportingMedia":[{"base64":false,"type":"text/html","value":"Medtronic has developed mitigating patches for a subset of the \naffected implanted cardiac device models. These patches are installed \nduring regular office visits. Medtronic has stated that patches for \nadditional impacted models are being developed by Medtronic and will be \ndeployed through future updates. Patches are currently available for the\n following affected models:
Medtronic has applied additional controls for monitoring and responding to improper use of the Conexus telemetry protocol by the affected implanted cardiac devices. Additional mitigations are being developed and will be deployed through future updates, assuming regulatory approval.
Medtronic recommends that users take additional defensive measures to minimize the risk of exploitation of these vulnerabilities. Specifically, users should:
Medtronic has released additional patient focused information.
\n\n